University of Alabama Initiated for NIAID-Sponsored COVID-19 Adaptive Study Evaluating Remdesivir

University of Alabama Initiated for NIAID-Sponsored COVID-19 Adaptive Study Evaluating Remdesivir

University of Alabama (UAB), involved in the original research behind remdesivir, is one of about 75 sites worldwide hosting a clinical trial to evaluate the drug for patients diagnosed with COVID-19. UAB was just activated and hence will commence signing up patients...

Pin It on Pinterest